Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Comparison of Sertraline and Nortriptyline in the Treatment of Major Depressive Disorder in Late Life

Bondareff, William, Alpert, Murray, Friedhoff, Arnold J., Richter, Ellen M., Clary, Cathryn M., Batzar, Evan·2000·American Journal of Psychiatry

Abstract

OBJECTIVE: This study was designed to evaluate the comparative efficacy and safety of sertraline and nortriptyline for the treatment of major depressive disorder in older adults. METHOD: A double-blind, parallel group design was used to compare 210 outpatients, 60 years of age and older, who met DSM-III-R criteria for major depressive episode and had a minimum Hamilton Depression Rating Scale score of 18. The patients were randomly assigned to 12 weeks of treatment with either sertraline (50-150 mg/day) or nortriptyline (25-100 mg/day). RESULTS: The safety profiles of the two treatments were similar except that nortriptyline treatment was associated with a significant increase in pulse rate, whereas sertraline was associated with a nonsignificant decrease. Efficacy of both drugs was similar for both treatments at all time points, with 71.6% (N=53 of 74) of the sertraline-treated patients and 61.4% (N=43 of 70) of the nortriptyline-treated patients achieving responder status by week 12. Time to response was also similar, with more than 75% of the improvement in scores on the Hamilton depression scale having occurred by week 6. Secondary efficacy measures (posttreatment measures of cognitive function, memory, and quality of life) revealed a significant advantage for sertraline treatment. CONCLUSIONS: Primary efficacy measures showed sertraline and nortriptyline to be similarly effective. With secondary outcome measures there was consistent evidence of an advantage for the sertraline-treated group. The clinical impact of these measures on the long-term well-being of elderly depressed patients should be examined in a study of maintenance treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.157.5.729

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 25

  1. Nair NP, Amin M, Holm P, Katona C, Klitgaard N, Ng Ying Kin NM, Kragh-Sorensen P, Kuhn H, Leek CA, Stage KB: Moclobemide and nortriptyline in elderly depressed patients: a randomized, multicentre trial against placebo. J Affect Disord 1995; 33:1–9 · DOI
  2. Georgotas A, McCue RE, Friedman E, Cooper TB: Response of depressive symptoms to nortriptyline, phenelzine and placebo. Br J Psychiatry 1987; 151:102–106 · DOI
  3. Roose SP, Glassman AH, Attia E, Woodring S: Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735–1739 · DOI · Paper page
  4. Miller MD, Pollock BG, Rifai AH, Paradis CF, Perel JM, George C, Stack JA, Reynolds CF III: Longitudinal analysis of nortriptyline side effects in elderly depressed patients. J Geriatr Psychiatry Neurol 1991; 4:226–230 · doi:10.1177/089198879100400409
  5. Tollefson GD, Bosomworth JC, Heiligenstein JH, Potvin JH, Holman SL: A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 1995; 7:89–104 · DOI
  6. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62 · DOI · Paper page
  7. Folstein MF, Folstein SE, McHugh PR: “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198 · DOI · Paper page
  8. Norcross JC, Guadagnoli E, Prochaska JO: Factor structure of the Profile of Mood States. J Clin Psychol 1984; 40:1270–1277 · DOI
  9. Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29:321–326 · DOI · Paper page
  10. Buschke H, Fuld PA: Evaluating storage, retention, and recall in disordered memory and learning. Neurology 1974; 24:1019–1025 · DOI · Paper page
  11. McCarthy M, Ferris S, Clark E, Crook T: Acquisition and retention of categorized material in normal aging and senile dementia. Exp Aging Res 1981; 7:127–135 · DOI
  12. Tremaine LM, Joerg EA: Automated gas chromatographic-electron-capture assay for the selective serotonin uptake blocker sertraline. J Chromatogr 1989; 496:423–429 · DOI
  13. Dhar AK, Kutt H: An improved gas-liquid chromatographic procedure for the determination of amitriptyline and nortriptyline levels in plasma using nitrogen-sensitive detectors. Ther Drug Monit 1979; 1:209–216 · doi:10.1097/00007691-197901020-00003
  14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statistical Assoc 1958; 53:457–481 · DOI · Paper page
  15. Feighner JP, Cohn JB: Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985; 46:20–25
  16. Altamura AC, De Novellis F, Guercetti G, Invernizzi G, Percudani M, Montgomery SA: Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. Int J Clin Pharmacol Res 1989; 9:391–396
  17. Fairweather DB, Kerr JS, Harrison DA: A double-blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 1993; 8:41–47 · DOI
  18. Guillibert E, Pelicier Y, Archambault JC: A double-blind multicenter study of paroxetine vs clomipramine in depressed elderly patients. Acta Psychiatr Scand Suppl 1989; 350:132–134 · DOI
  19. Pelicier Y, Schaeffer P: A multi-center, blind study to compare the efficacy and tolerability of paroxetine and clomipramine in elderly patients with reactive depression. Encephale 1993; 19:257–261
  20. Geretsegger C, Stuppaeck CH, Mair M: Multicenter double-blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology (Berl) 1995; 119:277–281 · DOI
  21. Young RC, Mattis S, Alexopoulos GS, Meyers BS, Shindledecer R, Dahr AK: Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline. Psychopharmacol Bull 1991; 27:291–294
  22. Weingartner H, Cohen RM, Murphy DL, Martello J, Gerdt C: Cognitive processes in depression. Arch Gen Psychiatry 1981; 38:42–47 · DOI · Paper page
  23. King DA, Caine ED, Conwell Y, Cox C: The neuropsychology of depression in the elderly: a comparative study of normal aging and Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1991; 3:163–168 · DOI
  24. King DA, Caine ED, Cox C: Predicting severity of depression in the elderly at 6 month follow-up: a neuropsychological study. J Neuropsychiatry Clin Neurosci 1991; 3:64–67 · doi:10.1176/jnp.3.1.64
  25. Pollock BG, Mulsant BH, Nebes R, Kirshner MA, Begley AE, Mazumdar S, Reynolds CF III: Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry 1998; 155:1110–1112 · DOI

Cited by

See all 202

Metadata

Authors
Bondareff, W., Alpert, M., Friedhoff, A. J., Richter, E. M., Clary, C. M., & Batzar, E.
Venue
American Journal of Psychiatry
Published
2000-05-01
Volume
157
Issue
5
Pages
729-736
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2158186000
Cited by
202
References
4
FWCI
8.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of Sertraline and Nortriptyline in the Treatment of Major Depressive Disorder in Late Life. https://app.cochat.ai/papers/10.1176/appi.ajp.157.5.729
The paper
Bondareff, W., Alpert, M., Friedhoff, A. J., Richter, E. M., Clary, C. M., & Batzar, E. (2000). Comparison of Sertraline and Nortriptyline in the Treatment of Major Depressive Disorder in Late Life. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.5.729

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.